Results 161 to 170 of about 332,373 (294)

Incidence Rates of First-Ever Ischemic Stroke Subtypes Among Blacks [PDF]

, 1999
Daniel Woo, James Gebel, Rosemary Miller, Rashmi Kothari, Thomas G. Brott, Jane Khoury, Shelia Salisbury, Rakesh Shukla, Arthur Pancioli, Edward C. Jauch, Joseph P. Broderick   +10 more
openalex   +1 more source

Aging and ischemic stroke

Aging, 2019
Mohammed Yousufuddin, Nathan P. Young
openaire   +3 more sources

Senkyunolide I Improves Septicemia‐Induced Brain Dysfunction via Regulating Nrf2 and Astrocyte Activity.

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Senkyunolide I (Sen I) has a protective effect on the blood–brain barrier (BBB) in rats with sepsis‐associated encephalopathy (SAE). This study investigated whether Sen I regulates Nrf2 to ameliorate sepsis‐induced brain dysfunction (SIBD). Sixty rats were randomly assigned into Sham group, SAE group (Model group), SAE + Sen I group (72 mg/kg,
Haohao Cao, Tao Liu, Meixia Xu
wiley   +1 more source

Bidirectional Role of Pericytes in Ischemic Stroke. [PDF]

Brain Sci
Xu J, Zhao W.
europepmc   +1 more source

Platelet Glycoprotein Receptor IIIa Polymorphism P1A2 and Ischemic Stroke Risk [PDF]

, 1998
Kathryn R. Wagner, Wayne H. Giles, Constance J. Johnson, Chin-Yih Ou, Paul F. Bray, Pascal J. Goldschmidt‐Clermont, Janet B. Croft, Vicki Brown, Barney J. Stern, B. R. Feeser, David W. Buchholz, Christopher J. Earley, Richard F. Macko, Robert McCarter, Michael A. Sloan, Paul D. Stolley, Robert J. Wityk, Marcella A. Wozniak, Thomas R. Price, Steven J. Kittner   +19 more
openalex   +1 more source

Solanidine‐derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Phenoconversion, a genotype‐phenotype mismatch, challenges a successful implementation of personalized medicine. The aim of this study was to detect and determine phenoconversion using the solanidine metabolites 3,4‐seco‐solanidine‐3,4‐dioic acid (SSDA) and 4‐OH‐solanidine as diet‐derived cytochrome P450 2D6 (CYP2D6) biomarkers in a ...
Jens Andreas Sarömba, Julian Peter Müller, Jolanta Tupiec, Anjali Roeth, Berkan Kurt, Florian Kahles, Thea Laurentius, Cornelius Bollheimer, Julia C. Stingl, Katja S. Just   +9 more
wiley   +1 more source

Advances in IV Thrombolysis for Acute Ischemic Stroke. [PDF]

JACC Asia
Mahajan R.
europepmc   +1 more source

Anticoagulation intensity and outcomes among southeast‐Asians with moderate‐to‐severe mitral valve stenosis

British Journal of Clinical Pharmacology, EarlyView.
Objective To determine the optimal anticoagulation intensity of warfarin in a South‐East Asian population with moderate‐to‐severe rheumatic mitral stenosis. Methods A multicentre, retrospective study examined patients with rheumatic mitral stenosis who had not undergone valve replacement or repair and required long‐term warfarin therapy at two ...
Punyawee Puchsaka, Wipharak Rattanavipanon, Sararat Phetroong, Rudeekorn Ue‐sethasakdhi, Suparat Wattanasombat, Wattana Wongtheptien, Surakit Nathisuwan   +6 more
wiley   +1 more source

Pharmacogenomics in the UK National Health Service: Progress towards implementation

British Journal of Clinical Pharmacology, EarlyView.
Over the past decade there has been considerable and growing enthusiasm about the promise of using genomics to inform healthcare. In particular, using genetic data to inform prescribing practice has emerged as a compelling policy priority for health systems around the world, not least in the NHS.
John H. McDermott, Maria Tsakiroglou, William G. Newman, Munir Pirmohamed   +3 more
wiley   +1 more source

Optimal timing for tracheostomy in severe ischemic stroke patients: early or standard incision? [PDF]

BMC Neurol
Guo C, Ye H, Chen X, Luo Y, Wu S, Sun X.
europepmc   +1 more source